financetom
Business
financetom
/
Business
/
Ligand Pharmaceuticals COO Matthew Korenberg to Step Down
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ligand Pharmaceuticals COO Matthew Korenberg to Step Down
Aug 5, 2024 4:44 AM

07:05 AM EDT, 08/05/2024 (MT Newswires) -- Ligand Pharmaceuticals ( LGND ) said Friday that its Chief Operating Officer, Matthew Korenberg, will leave the company.

The departure will be effective Oct. 31, unless Korenberg chooses to terminate his employment with the company before that.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved